San-Yu Wang1, I-Mei Lin2, Sheng-Yu Fan3, Yu-Che Tsai1, Cheng-Fang Yen4, Yi-Chun Yeh4, Mei-Feng Huang4, Yu Lee5, Nien-Mu Chiu5, Chi-Fa Hung5, Peng-Wei Wang4, Tai-Ling Liu4, Huang-Chi Lin4. 1. Department of Psychology, College of Humanities and Social Sciences, Kaohsiung Medical University, Taiwan. 2. Department of Psychology, College of Humanities and Social Sciences, Kaohsiung Medical University, Taiwan; Pervasive Artificial Intelligence Research (PAIR) Labs, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Taiwan. Electronic address: psyiml@kmu.edu.tw. 3. Institute of Gerontology, College of Medicine, National Cheng Kung University, Taiwan. 4. Department of Psychiatry, Kaohsiung Medical University Hospital, Taiwan; Graduate Institute of Medicine, and Department of Psychiatry, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. 5. Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan.
Abstract
BACKGROUND: Alpha-asymmetry neurofeedback (ALAY) was applied to patients with major depressive disorder (MDD) based on the theory of frontal alpha asymmetry. Neurophysiological studies have found a higher high-beta activity of electroencephalography (EEG) at the posterior cortex among patients with comorbid MDD and anxiety symptoms. The present study examined the effects of ALAY and high-beta down-training (Beta) neurofeedback in symptoms of depression and anxiety and EEG parameters. METHOD: Eighty-seven patients with comorbid MDD and anxiety symptoms were allocated to the ALAY, Beta, or control groups. Both neurofeedback groups received ten-session neurofeedback. All participants completed the Beck Depression Inventory II (BDI-II), Beck Anxiety Inventory (BAI), and five minutes resting EEG recording at pre-test and post-test. EEG raw signals were transformed into an A1 score [log (F4 alpha) - log (F3 alpha)], P3 and P4 high-beta power. RESULTS: BDI-II and BAI scores decreased at post-test in both ALAY and Beta groups, but no significant difference between the two groups. No significant interaction effect in A1 score at pre-test and post-test between the ALAY, Beta, and control groups. The P3 high-beta was significantly decreased in the Beta group, an increase in the control group, and no change in the ALAY group at post-test compared to the pre-test. CONCLUSIONS: Both neurofeedback groups decreased symptoms of depression and anxiety. The Beta group was more effective in decreasing high-beta power at the parietal cortex compared to other groups. This non-invasive psychological intervention can be used in the future for patients with comorbid MDD and anxiety symptoms.
BACKGROUND: Alpha-asymmetry neurofeedback (ALAY) was applied to patients with major depressive disorder (MDD) based on the theory of frontal alpha asymmetry. Neurophysiological studies have found a higher high-beta activity of electroencephalography (EEG) at the posterior cortex among patients with comorbid MDD and anxiety symptoms. The present study examined the effects of ALAY and high-beta down-training (Beta) neurofeedback in symptoms of depression and anxiety and EEG parameters. METHOD: Eighty-seven patients with comorbid MDD and anxiety symptoms were allocated to the ALAY, Beta, or control groups. Both neurofeedback groups received ten-session neurofeedback. All participants completed the Beck Depression Inventory II (BDI-II), Beck Anxiety Inventory (BAI), and five minutes resting EEG recording at pre-test and post-test. EEG raw signals were transformed into an A1 score [log (F4 alpha) - log (F3 alpha)], P3 and P4 high-beta power. RESULTS: BDI-II and BAI scores decreased at post-test in both ALAY and Beta groups, but no significant difference between the two groups. No significant interaction effect in A1 score at pre-test and post-test between the ALAY, Beta, and control groups. The P3 high-beta was significantly decreased in the Beta group, an increase in the control group, and no change in the ALAY group at post-test compared to the pre-test. CONCLUSIONS: Both neurofeedback groups decreased symptoms of depression and anxiety. The Beta group was more effective in decreasing high-beta power at the parietal cortex compared to other groups. This non-invasive psychological intervention can be used in the future for patients with comorbid MDD and anxiety symptoms.
Authors: Mikhail Ye Mel'nikov; Dmitriy D Bezmaternykh; Andrey A Savelov; Evgeniy D Petrovskiy; Lyudmila I Kozlova; Kira A Natarova; Tatiana D Larina; Tatiana M Andamova; Mikhail Zvyagintsev; Mark B Shtark; Klaus Mathiak Journal: Eur Arch Psychiatry Clin Neurosci Date: 2022-07-30 Impact factor: 5.760
Authors: Teresa López-Castro; Laura Martin; Sean Nickley; Tanya C Saraiya; Robert D Melara Journal: Clin EEG Neurosci Date: 2021-10-16 Impact factor: 2.046